Theophylline NDC 71335-2909

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-2909Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-2909Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71335-2909-1	71335290901	473 mL in 1 BOTTLE (71335-2909-1)Marketed from Oct 22, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Theophylline
Generic name (nonproprietary): theophylline
Active ingredients: Theophylline anhydrous — 80 mg/15mL
Dosage form: Solution
Route: Oral
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091586
Marketing start: Aug 2, 2012
Listing expires: Dec 31, 2026
Other FDA classes: Xanthines (Chemical structure)
Identifiers: Product ID 71335-2909_8f5bdf04-0913-42db-8349-7121a814b909SPL ID 8f5bdf04-0913-42db-8349-7121a814b909SPL set ID 62fb84a9-4e75-4f4b-8f15-1fd1bb7ae4ddRxCUI 313306UNII 0I55128JYK
Pharmacologic class: Methylxanthine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335290901 followed by a unit qualifier and the quantity

Package 71335-2909-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 22, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Theophylline oral solution is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)